drug · antibody drug conjugate
patient view →tisotumab vedotin
Marketedupdated 2mo agoby Genmab AS🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.
indications
investigational
NSCLC
targets
Tissue factorTubulin
all catalysts(4)
approval · 4
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that